Navigation Links
Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference
Date:8/30/2012

MONMOUTH JUNCTION, N.J., Aug. 30, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the treatment of serious lung infections, today announced that Timothy Whitten, President and Chief Executive Officer, will be presenting a corporate overview at the Stifel Nicolaus 2012 Healthcare Conference in Boston on Thursday, September 6, 2012, at 8:35 AM ET.

A live audio webcast will be made available on Insmed's website, http://www.insmed.com.  The webcast will also be archived for 30 days.

About Insmed
Insmed Incorporated is a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the treatment of serious lung infections, with a particular focus on orphan diseases.  Insmed's core expertise is the development of inhaled antibiotic therapy delivered via proprietary advanced liposomal pulmonary technology.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements
This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, our estimates regarding our capital requirements and our needs for additional financing, our ability to access additional funds under the Hercules loan agreement, results of operations, the status, results and timing of results of pre-clinical studies and clinical trials and pre-clinical and clinical data described herein, the timing of and costs associated with pre-clinical studies and clinical trials, the development of our products, our estimates of the size of the potential markets for our product candidates, and the business strategies, plans and objective
'/>"/>

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012
2. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
3. Insmed Incorporated Provides Corporate Update
4. Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics: Twease.org
5. Life Technologies to Present at UBS Global Life Sciences Conference
6. Companies Selected to Present at AdvaMed 2012 Announced
7. Walgreens Set to Present at CBIs 3rd Forum on Strategic Distribution Planning for Specialty Products
8. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
9. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
10. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
11. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... California (PRWEB) , ... September 02, 2015 , ... ... a critical demand to aid high-risk surgeries. From vital sign monitoring in ICU ... by Intel technology enables surgeon to make real-time clinical decisions with simultaneous access ...
(Date:9/1/2015)... September 2, 2015 ... die Forschung und Entwicklung neuartiger Therapien für ... Darmerkrankungen und Reizdarm konzentriert, erhält vom US ... sein neues Medikament patentiert wird. Das Medikament ... bei Kindern verhindert und Entzündungen vorbeugt.   ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Micro Confocal High-Content Imaging System. This transformative system fits a broad range ... models such as spheroids, tissues, and organisms. , The ImageXpress Micro ...
(Date:9/1/2015)... ... September 01, 2015 , ... Leading CEOs, CSOs, CMOs, and ... space join prominent academics and key investors for Neuro Advance Boston, October 14, ... Boston. , Neuro Advance Boston focuses on the latest developments and opportunities ...
Breaking Biology Technology:Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2
... Va., Nov. 9 CEL-SCI Corporation (NYSE Amex: CVM) ... Professor of Immunology and Microbiology of Northeastern Ohio Universities ... in collaboration with scientists at the Cleveland Clinic and ... was presented at the 7th GTCbio Vaccine: "All Things ...
... ... allowing veterinary research subjects, research facilities and research safety study data to be managed ... ... today that it has unveiled Pristima™ VM, an integrated enterprise software solution for research ...
... As global temperatures and energy costs continue to soar, ... sustainable future. An attractive replacement for gasoline ... Genome Research ( www.genome.org ), scientists have ... clues that will be critical in developing new technologies ...
Cached Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2
(Date:8/12/2015)... 2015  New research unveiled at Black Hat ... to steal users, fingerprints. Information released today by ... scanners on mobile devices, making the security of ... on mobile devices, HYPR Corp. recently released a ... systems with strong cryptographic security. More information on ...
(Date:8/6/2015)... 6, 2015  Today, U.S. Congressman Mike ... ™ to learn firsthand how Silicon Valley technologies ... is a world leader in multi-factor identity management ... helping federal agencies and commercial organizations achieve new ... "The vast majority of network breaches can ...
(Date:8/5/2015)... Aug. 5, 2015 The biosensors market is ... applications, penetration into newer sectors, and development of devices ... biosensors space has seen the entry of multiple participants ... far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( http://www.frost.com/nee9 ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... Ill. (September 25, 2008) A light-transmitting compound that ... and in sensors to detect biological and chemical weapons ... its structure was too difficult to examine. Luckily, ... and Northwestern University were able to determine the structure ...
... global scientific community will gather in Maputo, Mozambique, 21-24 ... International Council for Science (ICSU)the first time an ICSU ... than 250 leading scientists from around the world will ... address how science can contribute to solving some of ...
... green may be heart healthy if the green ... at Penn State who conducted the first study ... "We investigated mechanisms of action to explain the ... K. Gebauer, recent Penn State Ph.D. recipient, currently ...
Cached Biology News:Argonne scientists peer into heart of compound that may detect chemical, biological weapons 2Global science community to gather in Mozambique 2Researchers study how pistachios may improve heart health 2
... optically clear polystyrene formulation , High antibody-binding ... , Plates are certified for performance ... , Eight-well strips fit snugly in ... in use even if turned upside down ...
...
... StabilZyme SELECT Stabilizer is an aqueous ... and other non-toxic stabilizing chemicals in a ... contains a combination of 0.02% methylisothiazolone and ... SELECT Stabilizer is a diluent and stabilizer ...
... is a bovine protein-free alternative to StabilCoat ... solution that contains non-toxic chemicals in a ... - 7.2, and does not contain a ... of antibodies and other biomolecules that are ...
Biology Products: